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Over the past four decades, substantial evidence from exercise scientists around the 
globe have demonstrated the potential effects of regular physical activity (PA) and 
higher levels of cardiorespiratory fitness (CRF) against cardiovascular disease (CVD) and 
CVD- and all-cause mortality.1-3 Although a component of CRF may be genetic or 
inherited, the major part of CRF is derived from persistent and effective PA and exercise 
training.3 Although PA is extremely important,1-3 substantial data has suggested CRF 
predicts prognosis even more so than does PA.3-5 In fact, each one metabolic equivalent 
(MET) increase in CRF is associated with 13% and 15% reductions in all-cause mortality 
and CVD/coronary events, respectively, in a major meta-analysis.6 Additionally, in a 
study of over 14,000 subjects followed for over 11 years in the Aerobic Center 
Longitudinal Study (ACLS), Lee et al7 demonstrated that every one MET increase in CRF 
over time assessed in CRF examinations separated by an average of over six years was 
associated with all-cause and CVD-mortality reductions of 15% and 19%, respectively. 
These substantial data on the potential benefits of CRF (Table) have led some of us to 
suggest CRF should become a vital sign for clinical practices.8 
 
In the current issue of American Heart Journal, Davidson and her well-known co-
authors9 analyzed 8,171 male veterans followed for close to 9 years and determined the 
association/impact of PA and CRF on subsequent mortality (n = 1349 deaths). In 
analyses when either PA or CRF were adjusted for clinical factors, both were associated 
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reductions in mortality. Meeting national guidelines for PA (≥ 150 minutes per week of 
moderate PA assessed by questionnaire) was associated with a 17% lower risk of 
mortality (p = 0.001), and every one MET increase in CRF was associated with a 15% 
reduction in mortality (p <0.001), when both were adjusted for other clinical factors. 
However, in analyses including CRF, PA was no longer associated with lower mortality in 
either fit (defined as ≥ 7 METs) or unfit (< 7 METs), whereas when adjusted for PA, CRF 
and being fit was still associated with lower mortality, supporting data that CRF is 
superior to PA for predicting prognosis and supporting the potential measurement of 
CRF in clinical practices. 
 
We applaud Davidson and colleagues9 for adding to the literature on this topic, and their 
study clearly demonstrates that “Survival of the Fittest” is not only an unforgettable 
phrase, it is an unequivocal truth. And given that exercise frequency and/or intensity of 
PA/exercise training has been shown to have a positive impact on CRF,3 it can be posited 
that daily PA/exercise engenders both the “Arrival of the Fittest” as well as the “Survival 
of the Fittest”.  lthough investigators in Davidson’s study and elsewhere attempt to 
separate the benefits of PA and CRF, it may not be possible to completely separate PA 
and CRF biologically since much of CRF probably depends on current levels of PA. 
Therefore, their study is unable to definitively answer the question of whether the 
health-related effects of PA and CRF are derived from independent, inter-dependent or 
merely inter-related metabolic pathways. However, their study also supports that 
although PA may be a mediator, CRF is the clinical factor associated with a positive 
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prognosis. Whether this relationship between CRF and survival is causal or merely 
associated cannot be answered by this or similar studies, but clearly CRF is predictive of 
prognosis and survival.1-9 This study also raises the possibility that PA mediates its 
benefits via improving CRF and that although any PA may be superior to no PA, it can be 
posited that PA that does not effectively improve CRF may not be especially effective.  
Certainly, higher intensity PA more effectively increases CRF than does low intensity 
PA,3,10,11 and PA associated with significant increases in heart rate is more effective to 
improve CRF and survival than is PA at low heart rates. 12 In fact, we recently 
demonstrated that a Personalized Activity Intelligence (PAI) with PA at higher heart 
rates predicts survival considerably better than did PA meeting national guidelines.12   
 
Although assessment of CRF in clinical settings may seem ideal, often this is considered 
impractical from a time and cost perspective. Obviously, if CRF could be assessed quickly 
(in seconds or minutes as opposed to 15-30 minute stress tests) and inexpensively (e.g. 
$50-100 as opposed to clinical stress tests that currently typically cost > $1,000), routine 
CRF testing could be possible throughout clinical medicine. However, this is certainly not 
the case presently. Nevertheless, non-exercise assessments of CRF have been published 
from the ACLS,14 NHANES,15 and HUNT16 databases, and others,8 demonstrating the 
predictive value of estimated CRF without more precisely measuring it by treadmill or 
other exercise assessments.  These estimated CRF assessments could easily be included 
in future clinical evaluations and electronic medical records to help clinicians further 
stratify risk in their patients. 
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Although the efforts of Davidson and colleagues9 is noteworthy, this study is not 
without limitations.  While they provide a strong analysis of the existing data, the use of 
self-reported (memory-based) data on PA and dichotomization of a continuous variable 
(i.e. CRF) limits their conclusions. As we demonstrated recently in the field of nutrition, 
there are often large and significant clinically relevant differences between self-reported 
lifestyle behaviors (e.g. diet and exercise) and objective measures.17,18 Fortunately, 
exercise scientists now have objective and accurate measures to quantify PA, and 
further efforts should eventually and precisely define the relative contributions of PA 
and CRF to health and well-being.19-23  Second, determining CRF by treadmill speed and 
incline is not the same as precise measurements of oxygen consumption (VO2) 
determined with gas exchange.24  Third, PA and CRF are continuous variables and to 
reduce this to discreet cut-points results in a potential enormous loss of information.  
Finally, the arbitrary cut-off of CRF for Fit versus Unfit ≥ 7 METs introduces potential 
measurement and classification errors. For example, does a 6.9 MET measurement on a 
fitness test really represent lower fitness than a 7.1 MET level? And while 7 METs may 
not be very fit for a 30-40 year-old male, it may represent a quite good level of fitness 
for an 80 year old.  
  
Despite these potential study limitations, we think that this study is a valuable 
contribution to the field of exercise sciences in this area. Although it would be ideal to  
be able to instruct a patient to obtain a higher level of CRF, we have no control over 
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genetic or inherited traits.  Therefore, without having a “Fitness Pill,”25,the best current 
approach is to recommend not only PA, but more effective PA to improve levels of CRF, 
including higher intensity PA that effectively increases heart rates.10-12  Finally, efforts 
are desperately needed throughout the healthcare systems in the United States and 
throughout the world to increase the PA of the population. 1-3,26,27 Increasing PA is a 
cost-effective strategy28 to improve CRF, resulting in reduction of healthcare costs as 
well as CVD and all-cause mortality in our patients and the global population.29 
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Table 1.  Potential Benefits or Associations of Cardiorespiratory Fitness with Improved 
Prognosis. 
 
Physiological Benefits 
Reduced blood pressure Improved insulin sensitivity 
Improved heart rate variability Decreased myocardial oxygen demands 
Improved myocardial function Maintain lean mass 
Improved endothelial function Reduced visceral adiposity 
Reduced blood and plasma viscosity Increased capillary density 
Increased mitochondrial density Improved mood and psychological stress 
Reduced systemic inflammation Improved sleep 
Reduced Risk of Developing: 
Hypertension Osteoporosis  
Depression Osteoarthritis 
Metabolic syndrome Dementia and Alzheimer's disease 
Diabetes mellitus Breast, colon, and other cancers 
 
 
